Here are three biotech companies with promising innovations that could provide catalysts for their respective stocks in 2023 More
Articles
Why NIO Stock Will Continue Heading Downward
But given how far this stock has fallen, if an improvement in its fortunes takes shape, there will be plenty of time to enter a position. Until then, play it safe. Stay away from NIO stock. More
Don’t Count on a Comeback for Lucid Stock
Even as Lucid Group upgrades some of its vehicles with a dark, "stealthy" appearance, LCID stock remains on the fast track to major losses. More